By Norma Erickson, President Medical consumers worldwide applaud the recent FDA decision not to expand the use of Gardasil to women over the age of 26. Now they want to know when the FDA will admit the original approval may have been a mistake. FOR IMMEDIATE RELEASE PRLog (Press Release) – Apr 12, 2011 – […]
SANE Vax, Inc. presents global concerns about HPV vaccines at the British Society for Ecological Medicine Conference
Natural News Monday, April 04, 2011 Posted by: Rosemary Mathis, Director of SANE VAX, INC. Written by: Leslie Carol Botha April 5, 2011 On March 11, Freda Birrell, Scotland, and Leslie Carol Botha, U.S., participated in the British Society for Ecological Medicine Spring Scientific Meeting in London, titled: ‘A tablet a day keeps the patient […]
Behind the Scenes: The Evolution of an HPV Industry
By Norma Erickson, President of SaneVax Inc. April 5, 2011 The first papillomavirus was discovered in the 1930’s by Dr. Richard E. Shope. It was the cottontail rabbit papillomavirus, or the Shope papillomavirus, which occurred in warts that frequently developed into cancerous tumors1. Dr. Shope was able to isolate the virus, inject it into […]
Fast-Tracking Oncology Drugs Questioned
MedPage Today By Kristina Fiore, Staff Writer, MedPage Today Published: March 27, 2011 Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner Cancer drugs rushed to the market via the FDA’s accelerated approval process often languish in confirmatory trials, agency researchers say. Out […]
HPV Genotyping Clinical Guidelines?
SANE Vax, Inc. By Norma Erickson March 27, 2011 HPV Genotyping Clinical Update National Cancer Institute studies have shown that women with HPV types 16 and 18 have about a 20% risk of progressing to CIN3 over 10 years despite negative Pap tests, and colposcopy may be useful for these women. However, most HPV […]
- « Previous Page
- 1
- …
- 38
- 39
- 40
- 41
- 42
- …
- 51
- Next Page »
